ABT vs GILD

A side-by-side look at ABT and GILD, updated throughout the trading session.

ABTABT Open ABT on Vela

GILDGILD Open GILD on Vela

Performance, normalized

Z-scored closes: both paths on one scale, price levels aside.

Loading history…

Live figures are refreshing. Check back in a moment.

ABT vs GILD: how they differ

Abbott Laboratories (ABT) and Gilead Sciences, Inc. (GILD) are both in the Healthcare sector: ABT is classified in Medical - Devices, GILD in Drug Manufacturers - General. ABT trades on NYSE and GILD on NASDAQ.

ABT trades about 10.5 million shares a day on average, against 6.6 million for GILD. ABT has the higher beta (0.58 against 0.33 for GILD), meaning it has historically moved more with the broad market. Over the trailing twelve months, ABT paid $2.52 per share in dividends and GILD paid $3.25 per share.

Figures as of October 25, 2026.

The chart Z-score-normalizes each closing series, computing (close − mean) ÷ standard deviation over the window, so both paths share one scale regardless of price level, and correlation is computed on daily returns. Figures update throughout the trading session. Nothing on this page is financial advice.